| 5383 |
Centers for Disease Control and Prevention |
Html |
en |
Diagnosis - FASD |
FASDs are 100% preventable if a woman does not drink alcohol during pregnancy. There is no known safe amount of alcohol to drink while pregnant. There is also no safe time during pregnancy to drink and no safe kind of alcohol. |
| clinical diagnosis | 0.465105 |
| different ways | 0.456061 |
| common parenting practices | 0.524661 |
| Abnormal facial features | 0.562704 |
| functional problems | 0.463265 |
| new way | 0.523216 |
| general audience | 0.441567 |
| social skills problems | 0.574715 |
| Attention problems | 0.462314 |
| growth problems | 0.553237 |
| text Fetal Alcohol | 0.620506 |
| similar symptoms | 0.441611 |
| health care professionals | 0.557378 |
| Fetal alcohol spectrum | 0.644717 |
| alcohol exposure | 0.462767 |
| growth issues | 0.442589 |
| Executive functioning deficits | 0.606556 |
| mother drank alcohol | 0.840371 |
| fas diagnosis | 0.829993 |
| nervous system problems | 0.722913 |
| social skills | 0.647647 |
| difficulty | 0.518083 |
| Confirmed alcohol | 0.478645 |
| person | 0.604932 |
| following signs | 0.441713 |
|
| fine motor skills | 0.543488 |
| structural differences | 0.438374 |
| problems | 0.750462 |
| healthcare providers | 0.440508 |
| nervous system criteria | 0.477149 |
| physical problems | 0.501524 |
| poor sucking | 0.437637 |
| diagnostic guidelines | 0.444138 |
| facial features | 0.572669 |
| Cognitive deficits | 0.48207 |
| Growth deficits | 0.48555 |
| alcohol-related neurodevelopmental disorder | 0.573289 |
| fetal alcohol syndrome | 0.872589 |
| term FASDs | 0.454174 |
| gross motor skills | 0.540987 |
| diagnostic criteria | 0.459495 |
| scientific research | 0.44738 |
| developmental delays | 0.440353 |
| information purposes | 0.436125 |
| Healthcare professionals | 0.436523 |
| person manage life | 0.584257 |
| poor organization | 0.436203 |
| balance problems | 0.462661 |
| FAS | 0.997171 |
|
CLICK HERE |
| 6779 |
Centers for Disease Control and Prevention |
Html |
en |
Cholera - Treatment - Zinc Treatment |
Children who received zinc supplementation had 8 fewer hours of diarrheal illness and 10% less diarrheal stool volume, on average. |
| average | 0.525087 |
| treatment | 0.521947 |
| Mah-e-Muneer | 0.520998 |
| study | 0.57628 |
| R. Zinc supplementation | 0.872036 |
| similar effect | 0.624988 |
| Shafique | 0.520963 |
| Chakraborty | 0.537488 |
| diarrheal illness | 0.659339 |
| duration | 0.533745 |
| zinc supplementation | 0.997568 |
| Chowdhury | 0.572684 |
| intervention group | 0.63247 |
| children | 0.696965 |
| infections | 0.525346 |
| Hossain MJ | 0.641346 |
|
| hospital | 0.523681 |
| cholera symptoms | 0.700729 |
| severity | 0.536337 |
| diarrheal stool volume | 0.77395 |
| Khatun | 0.521138 |
| mg zinc | 0.703938 |
| onset | 0.53295 |
| rehydration therapy | 0.644889 |
| UNICEF/WHO. Diarrhoea | 0.62433 |
| Begum | 0.539265 |
| BMJ. | 0.522039 |
| Bangladesh | 0.563923 |
| Khanam | 0.539069 |
| pediatric diarrhea | 0.660565 |
| Roy SK | 0.627329 |
|
CLICK HERE |
| 7776 |
Centers for Disease Control and Prevention |
Html |
en |
Smallpox - Health Communication |
Gateway to Health Communication and Social Marketing Practice - Smallpox |
| general public | 0.48282 |
| skin disorders | 0.480806 |
| bioterrorism | 0.474777 |
| special two-pronged needle | 0.549687 |
| face-to-face contact | 0.480358 |
| interagency investigation | 0.474024 |
| related live virus | 0.578534 |
| Disease Control | 0.485624 |
| severe vaccine reactions | 0.604946 |
| smallpox vaccine | 0.694446 |
| hot water | 0.477303 |
| bioterrorist attack | 0.477243 |
| saliva droplets | 0.489411 |
| National Institutes | 0.473213 |
| senior physician | 0.535985 |
| special immune globulins | 0.547503 |
| upcoming clinical trial | 0.538483 |
| emergency basis | 0.477862 |
| smallpox | 0.900128 |
| early course | 0.475892 |
| routine smallpox vaccination | 0.738287 |
| smallpox virus | 0.69649 |
| biological threat | 0.47186 |
| intentional release | 0.473945 |
| variola virus | 0.526941 |
|
| health authorities | 0.472959 |
| lab exposure | 0.485288 |
| significant localized reaction | 0.550315 |
| characteristic rash | 0.497201 |
| severe residual scarring | 0.560544 |
| red flat lesions | 0.569511 |
| naturally contracting smallpox | 0.703174 |
| local health department | 0.531956 |
| biological agent | 0.474064 |
| local police department | 0.533246 |
| biological incident | 0.472094 |
| disease | 0.513213 |
| smallpox attack | 0.654991 |
| susceptible person | 0.482224 |
| quaternary ammonia | 0.477456 |
| hospital residents | 0.472369 |
| antiviral drugs | 0.484966 |
| aerosol release | 0.474694 |
| smallpox recover | 0.67506 |
| people | 0.473367 |
| suppressed immunity | 0.484585 |
| infected person | 0.479531 |
| study site | 0.475235 |
| high fever | 0.490082 |
|
CLICK HERE |
| 8459 |
Centers for Disease Control and Prevention |
Html |
en |
Frequently Asked Questions - About The Tips Campaign - Tips From Former Smokers - Smoking & Tobacco Use |
Answers to frequently asked questions about the Tips from Former Smokers campaign, including the why the campaign is running, the effectiveness of using graphic ads, whether the campaign features real people, and issues around to health conditions and diseases related to smoking and exposure to secondhand smoke. |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 9468 |
Centers for Disease Control and Prevention |
Html |
es |
Logro de una tasa de respuesta alta en una encuesta a proveedores de atención médica, estado de Washington, 2006 |
null |
| Dilley JA | 0.779573 |
| Estados Unidos | 0.903916 |
|
| Chronic Dis | 0.726246 |
| auxiliares médicos | 0.606863 |
|
CLICK HERE |
| 10685 |
Centers for Disease Control and Prevention |
Html |
en |
Smallpox' Communicating in the First Hours |
The CERC training program educates people on the principles and application of crisis and emergency risk communication when responding to a public health emergency. |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 12193 |
Centers for Disease Control and Prevention |
Html |
en |
Mold - General Information - Facts About Mold andDampness |
CDC Mold Web site provides information on mold and health, an inventory of state indoor air quality programs, advice on assessment, cleanup efforts, and prevention of mold growth, and links to resources. |
| health risk | 0.60775 |
| obstructive lung disease | 0.611202 |
| hypersensitivity pneumonitis | 0.563132 |
| mix bleach | 0.573312 |
| early mold exposure | 0.794458 |
| mold allergies | 0.742342 |
| nasal stuffiness | 0.565454 |
| sufficient evidence | 0.618753 |
| idiopathic pulmonary hemorrhage | 0.614661 |
| compost piles | 0.561831 |
| susceptible individuals | 0.567688 |
| eye irritation | 0.575383 |
| humidity levels | 0.69617 |
| healthy children | 0.601272 |
| mold growth | 0.805836 |
| skin irritation | 0.576274 |
| World Health Organization | 0.614387 |
| housing conditions | 0.559713 |
| mold | 0.9639 |
| moisture | 0.577946 |
| indoor exposure | 0.574523 |
| molds | 0.570145 |
| chronic lung illnesses | 0.606193 |
| respiratory allergies | 0.567313 |
| throat irritation | 0.575197 |
|
| moisture problem | 0.570183 |
| respiratory illness | 0.566803 |
| potential link | 0.560079 |
| respiratory tract symptoms | 0.722021 |
| household laundry bleach | 0.619743 |
| Immune-compromised people | 0.574658 |
| adverse health effects | 0.689082 |
| suggestive evidence | 0.60861 |
| upper respiratory tract | 0.721707 |
| indoor environments | 0.603224 |
| moldy environments | 0.569707 |
| Wear non-porous gloves | 0.598496 |
| protective eye wear | 0.59438 |
| indoor mold exposure | 0.803003 |
| people | 0.617147 |
| acute idiopathic hemorrhage | 0.612249 |
| mold inhibitors | 0.712642 |
| home | 0.589832 |
| air conditioning systems | 0.611773 |
| wood products | 0.560202 |
| paper products | 0.560259 |
| immune-mediated condition | 0.563961 |
| Indoor Air Quality | 0.619984 |
| asthma symptoms | 0.633017 |
|
CLICK HERE |
| 13363 |
Centers for Disease Control and Prevention |
Html |
en |
Rat Bite Fever | CDC |
null |
| Streptobacillus moniliformis | 0.830505 |
| People | 0.35395 |
| consumption | 0.387794 |
| occurs | 0.441111 |
| North America | 0.626667 |
| Haverhill fever | 0.719079 |
| Streptobacillary RBF | 0.97902 |
| different bacteria | 0.696058 |
| Rat-bite fever | 0.851469 |
|
| infectious disease | 0.651868 |
| Asia | 0.355212 |
| contaminated food | 0.650055 |
| RBF | 0.987795 |
| spirillary RBF | 0.968596 |
| infected rodents | 0.705254 |
| sodoku | 0.355904 |
| fatal disease | 0.616551 |
|
CLICK HERE |
| 14421 |
Centers for Disease Control and Prevention |
Html |
en |
Prescription Opioids |
null |
| prescription opioid overdose | 0.95004 |
| 2013—with wide variation | 0.266831 |
| privately insured patients | 0.260018 |
| primary care sample | 0.257849 |
| highest prescribing state | 0.273247 |
| Logan JE | 0.252986 |
| Ann Intern Med. | 0.239146 |
| prescription opioids | 0.742081 |
| Prescription Rates | 0.30479 |
| Health care providers | 0.286606 |
| opioid pain relievers | 0.850512 |
| Prevention. Vital Signs | 0.243433 |
| National Prescription Audit | 0.368064 |
| risk factors | 0.253678 |
| opioid prescribing patterns | 0.603055 |
| Opioid Pain Reliever | 0.68436 |
| Merrill JO | 0.249486 |
| prescription opioid pain | 0.821022 |
| Long-Term Opioid Users | 0.582232 |
| Inappropriate prescribing practices | 0.271357 |
| Health Care Poor | 0.255758 |
| Opioid use behaviors | 0.542424 |
| Kaplan JA | 0.2588 |
| Hall AJ | 0.250357 |
| opioid overdose deaths | 0.733317 |
|
| Halverson J. Doctor | 0.240827 |
| prescription opioid abuse | 0.899596 |
| textual cause-of-death data | 0.244583 |
| Heimer R. Epidemiologic | 0.241397 |
| moderate-to-severe pain | 0.265422 |
| opioid overdose-related deaths | 0.599837 |
| unintentional pharmaceutical overdose | 0.319351 |
| Drug Alcohol Depend | 0.253457 |
| opioid prescriptions | 0.685277 |
| drug overdose deaths | 0.332574 |
| lower sex drive | 0.262103 |
| opioid analgesics | 0.615688 |
| daily opioid therapy | 0.604949 |
| Pharmacy Shopping | 0.228142 |
| fatal opioid intoxications | 0.575262 |
| C. Prescription Practices | 0.351199 |
| Banta-Green CJ | 0.252799 |
| long-term opioid therapy | 0.645068 |
| opioid therapy | 0.685987 |
| et al | 0.509554 |
| lowest prescribing state | 0.276822 |
| primary care | 0.263058 |
| non-cancer pain | 0.25774 |
| chronic pain patients | 0.311381 |
|
CLICK HERE |
| 15773 |
Centers for Disease Control and Prevention |
Html |
en |
Skin Cancer: MedlinePlus |
Try ABCDE on a mole to check for signs of skin cancer: Asymmetry, Border, Color, Diameter, Elevation. Learn more on advanced detection and treatments. |
| skin cancer | 0.936926 |
| biologic therapy | 0.716466 |
| hands | 0.345873 |
| United States | 0.543366 |
| photodynamic therapy | 0.514781 |
| changes | 0.336909 |
| suspicious skin markings | 0.712017 |
| chemotherapy | 0.350073 |
| common types | 0.514587 |
| drug | 0.335826 |
| head | 0.339725 |
| common form | 0.51824 |
| skin cancer cells | 0.65996 |
| ability | 0.336607 |
|
| squamous cell cancer | 0.744204 |
| PDT | 0.455377 |
| organs | 0.343049 |
| tissues | 0.349924 |
| laser light | 0.503258 |
| melanoma | 0.357106 |
| neck | 0.348071 |
| people | 0.338019 |
| way | 0.336834 |
| doctor | 0.337109 |
| Treatment | 0.338314 |
| basal cell cancer | 0.742964 |
| radiation therapy | 0.489581 |
|
CLICK HERE |